REPL

5.40

0.37% 0.02

Dopo l'orario di chiusura: 5.45 0.05 +0.93%

Replimune Group Inc (REPL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$5.38

Aprire:

$5.36

Volume 24 ore:

2.25M

Relative Volume:

0.28

Capitalizzazione di mercato:

$421.50M

Reddito:

Utile/perdita netta:

$-209.96M

Rapporto P/E:

-1.7089

EPS:

-3.16

Flusso di cassa netto:

$-176.27M

1 W Prestazione:

-4.76%

1M Prestazione:

+44.00%

6M Prestazione:

-57.26%

1 anno Prestazione:

-51.18%

Intervallo 1D:

$5.33

$5.54

Intervallo di 1 settimana:

$5.33

$5.91

Portata 52W:

$2.68

$17.00

Replimune Group Inc Stock (REPL) Company Profile

Nome

Replimune Group Inc

Settore

Healthcare (1145)

Industria

Biotechnology (641)

Telefono

(781) 222-9600

Indirizzo

500 UNICORN PARK, WOBURN, MA

Dipendente

479

Cinguettio

@Replimune

Prossima data di guadagno

2025-02-11

Ultimi documenti SEC

REPL's Discussions on Twitter

Confronta REPL con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
REPL Replimune Group Inc	5.40	419.94M	0	-209.96M	-176.27M	-3.16
VRTX Vertex Pharmaceuticals Inc	391.02	100.52B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	580.70	61.43B	14.21B	4.46B	3.56B	39.68
ALNY Alnylam Pharmaceuticals Inc	446.51	59.29B	2.46B	-319.09M	-52.09M	-2.47
ARGX Argen X Se Adr	712.20	43.09B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	306.05	35.42B	3.81B	-644.79M	-669.77M	-6.24

Replimune Group Inc Stock (REPL) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-07-30	Aggiornamento	Cantor Fitzgerald	Neutral → Overweight
2025-07-23	Downgrade	BMO Capital Markets	Outperform → Underperform
2025-07-23	Downgrade	Barclays	Overweight → Equal Weight
2025-07-23	Downgrade	H.C. Wainwright	Buy → Neutral
2025-07-22	Downgrade	JP Morgan	Overweight → Neutral
2025-07-22	Downgrade	Leerink Partners	Outperform → Market Perform
2025-07-22	Downgrade	Piper Sandler	Overweight → Neutral
2025-07-22	Downgrade	Wedbush	Outperform → Neutral
2025-06-20	Iniziato	Cantor Fitzgerald	Overweight
2024-08-28	Iniziato	ROTH MKM	Buy
2023-04-17	Ripresa	Piper Sandler	Overweight
2021-11-19	Iniziato	Piper Sandler	Overweight
2021-10-15	Ripresa	BTIG Research	Buy
2020-11-17	Iniziato	BTIG Research	Buy
2020-11-02	Iniziato	Jefferies	Buy
2020-10-15	Aggiornamento	H.C. Wainwright	Neutral → Buy
2020-07-01	Downgrade	H.C. Wainwright	Buy → Neutral
2020-05-05	Iniziato	Barclays	Overweight
2019-09-04	Iniziato	ROTH Capital	Buy
2019-07-23	Iniziato	Chardan Capital Markets	Buy
2019-07-12	Aggiornamento	JP Morgan	Neutral → Overweight
2019-07-08	Iniziato	H.C. Wainwright	Buy
2019-04-25	Iniziato	Wedbush	Outperform
2019-01-23	Downgrade	JP Morgan	Overweight → Neutral
2018-08-14	Iniziato	JP Morgan	Overweight
2018-08-14	Iniziato	Leerink Partners	Outperform

Mostra tutto

Replimune Group Inc Borsa (REPL) Ultime notizie

11:13 AM

Class Action Lawsuit Filed: Replimune Group, Inc. (REPL)Join by September 22, 2025 – Contact Levi & Korsinsky - ACCESS Newswire

11:13 AM

06:05 AM

Can Replimune Group Inc. continue delivering strong returnsQuarterly Market Summary & Proven Capital Preservation Tips - خودرو بانک

06:05 AM

Aug 31, 2025

Can you recover from losses in Replimune Group Inc.July 2025 Selloffs & Reliable Trade Execution Plans - Newser

Aug 31, 2025

Replimune Faces Big Swings After FDA Setback And Cash Concerns - Finimize

Aug 31, 2025

News impact scoring models applied to Replimune Group Inc.Portfolio Update Report & Weekly Setup with High ROI Potential - Newser

Aug 31, 2025

Aug 30, 2025

Detecting support and resistance levels for Replimune Group Inc.Quarterly Portfolio Report & Consistent Return Strategy Ideas - Newser

Aug 30, 2025

Kessler Topaz Meltzer & Check, LLP Encourages Replimune Group, Inc. Investors With Losses to Contact the Firm - NewMediaWire

Aug 30, 2025

Identifying reversal signals in Replimune Group Inc.July 2025 Selloffs & Verified Momentum Stock Ideas - Newser

Aug 30, 2025

Replimune Group Inc. Builds Base for Possible Rebound getLinesFromResByArray error: size == 0 - thegnnews.com

Aug 30, 2025

Bragar Eagel & Squire, P.C. Reminds Investors of Class - GlobeNewswire

Aug 30, 2025

Bragar Eagel & Squire, P.C. Reminds Investors of Class Actions Against Neogen, Alto, RxSight, and Replimune and Encourages Investors to Contact the Firm - GlobeNewswire Inc.

Aug 30, 2025

Risk vs reward if holding onto Replimune Group Inc.2025 Winners & Losers & Low Risk Investment Opportunities - Newser

Aug 30, 2025

How to build a dashboard for Replimune Group Inc. stockPrice Action & AI Driven Stock Movement Reports - Newser

Aug 30, 2025

Aug 29, 2025

Faruqi & Faruqi Reminds Replimune Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025REPL - Morningstar

Aug 29, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines – REPL | FinancialContent - FinancialContent

Aug 29, 2025

REPL Class Action Lawsuit Reminder: Kessler Topaz Meltzer & - GlobeNewswire

Aug 29, 2025

Aug 28, 2025

Replimune Group Inc. stock prediction for this weekMarket Growth Summary & Stock Portfolio Risk Control - Newser

Aug 28, 2025

REPL Class Action Reminder: Investors with Large Losses Should Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in the Replimune Group, Inc. Class Action Lawsuit - PR Newswire

Aug 28, 2025